<DOC>
	<DOCNO>NCT00003264</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness cisplatin plus gemcitabine treating patient advance squamous cell head neck cancer treat surgery radiation therapy .</brief_summary>
	<brief_title>Cisplatin Plus Gemcitabine Treating Patients With Advanced Squamous Cell Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate response rate toxicity weekly cisplatin gemcitabine patient recurrent metastatic squamous cell carcinoma head neck receive either prior chemotherapy one prior chemotherapy regimen advance disease . OUTLINE : Patients stratify accord prior chemotherapy status : chemotherapy naive ( prior chemotherapy , prior neoadjuvant adjuvant chemotherapy least 6 month prior recurrence , prior biologic agent ) vs chemotherapy expose ( one prior chemotherapy regimen direct recurrent newly diagnose metastatic disease and/or prior neoadjuvant adjuvant chemotherapy le 6 month prior recurrence ) . Patients receive gemcitabine 30 minute infusion weekly 3 week follow one week rest . Cisplatin administer 30-60 minute infusion immediately precede gemcitabine . Treatment repeat every 28 day 2-6 course , depend response . Patients previously untreated metastatic disease may treatment interrupt receive radiation therapy locoregional disease site . Patients may continue treatment beyond 6 course discretion physician . Patients follow every 3 month . PROJECTED ACCRUAL : This study accrue approximately 36 patient .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven squamous cell carcinoma head neck consider incurable surgery radiation therapy Bidimensionally measurable disease readily evaluable disease either physical exam radiography Biopsy proven recurrence follow completion radiotherapy require site measurable disease within previous radiation port PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 2000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Neurologic : Peripheral sensory neuropathy great grade 1 Other : No significant active infection ( patient WBC 12,000/mm3 great , fever 100.6 degree F high , must evaluate rule occult infection ) Not pregnant nursing Effective contraception require fertile patient No active second malignancy PRIOR CONCURRENT THERAPY : Biologic therapy : Prior biologic therapy ( interleukin2 , interferon , monoclonal antibody , and/or retinoids ) permit Recovered prior biologic therapy Chemotherapy : No one prior chemotherapy regimen advance relapsed disease No chemotherapy within 4 week prior study Prior neoadjuvant radiosensitizing chemotherapy allow Endocrine therapy : Not specify Radiotherapy : Prior radiotherapy permit Recovered prior radiotherapy Surgery : Recovered major surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>salivary gland squamous cell carcinoma</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
</DOC>